Improving the prognosis and cure rate of HGOSs (high-grade osteosarcomas) is an absolute need. Immune-based treatment approaches have been increasingly taken into consideration, in particular for metastatic, relapsed and refractory HGOS patients, to ameliorate the clinical results currently achieved. This review is intended to give an overview on the immunotherapeutic treatments targeting, counteracting or exploiting the different immune cell compartments that are present in the HGOS tumor microenvironment. The principle at the basis of these strategies and the possible mechanisms that HGOS cells may use to escape these treatments are presented and discussed. Finally, a list of the currently ongoing immune-based trials in HGOS is provided, together with the results that have been obtained in recently completed clinical studies. The different strategies that are presently under investigation, which are generally aimed at abrogating the immune evasion of HGOS cells, will hopefully help to indicate new treatment protocols, leading to an improvement in the prognosis of patients with this tumor.

Hattinger, C.M., Salaroglio, I.C., Fantoni, L., Godel, M., Casotti, C., Kopecka, J., et al. (2023). Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(1), 1-29 [10.3390/ijms24010799].

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma

Fantoni, Leonardo;Casotti, Chiara;
2023

Abstract

Improving the prognosis and cure rate of HGOSs (high-grade osteosarcomas) is an absolute need. Immune-based treatment approaches have been increasingly taken into consideration, in particular for metastatic, relapsed and refractory HGOS patients, to ameliorate the clinical results currently achieved. This review is intended to give an overview on the immunotherapeutic treatments targeting, counteracting or exploiting the different immune cell compartments that are present in the HGOS tumor microenvironment. The principle at the basis of these strategies and the possible mechanisms that HGOS cells may use to escape these treatments are presented and discussed. Finally, a list of the currently ongoing immune-based trials in HGOS is provided, together with the results that have been obtained in recently completed clinical studies. The different strategies that are presently under investigation, which are generally aimed at abrogating the immune evasion of HGOS cells, will hopefully help to indicate new treatment protocols, leading to an improvement in the prognosis of patients with this tumor.
2023
Hattinger, C.M., Salaroglio, I.C., Fantoni, L., Godel, M., Casotti, C., Kopecka, J., et al. (2023). Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(1), 1-29 [10.3390/ijms24010799].
Hattinger, Claudia Maria; Salaroglio, Iris Chiara; Fantoni, Leonardo; Godel, Martina; Casotti, Chiara; Kopecka, Joanna; Scotlandi, Katia; Ibrahim, Ton...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/963985
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact